BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10759233)

  • 1. Apolipoprotein E polymorphism in alagille syndrome and progressive familial intrahepatic cholestasis.
    Socha P; Nowicka G; Jankowska I; Rujner J; Pawłowska J; Socha J
    Dig Dis Sci; 2000 Apr; 45(4):675-9. PubMed ID: 10759233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis.
    Jacquemin E; Hermans D; Myara A; Habes D; Debray D; Hadchouel M; Sokal EM; Bernard O
    Hepatology; 1997 Mar; 25(3):519-23. PubMed ID: 9049190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of progressive familial intrahepatic cholestasis: liver transplantation or partial external biliary diversion.
    Ismail H; Kaliciński P; Markiewicz M; Jankowska I; Pawłowska J; Kluge P; Eliadou E; Kamiński A; Szymczak M; Drewniak T; Revillon Y
    Pediatr Transplant; 1999 Aug; 3(3):219-24. PubMed ID: 10487283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood--clinical and biochemical effects].
    Kardorff R; Melter M; Rodeck B; Brodehl J
    Klin Padiatr; 1996; 208(3):118-22. PubMed ID: 8676599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
    Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
    Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy.
    Wanty C; Joomye R; Van Hoorebeek N; Paul K; Otte JB; Reding R; Sokal EM
    Acta Gastroenterol Belg; 2004; 67(4):313-9. PubMed ID: 15727074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total biliary diversion as a treatment option for patients with progressive familial intrahepatic cholestasis and Alagille syndrome.
    van der Woerd WL; Kokke FT; van der Zee DC; Houwen RH
    J Pediatr Surg; 2015 Nov; 50(11):1846-9. PubMed ID: 26319776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile composition in Alagille Syndrome and PFIC patients having Partial External Biliary Diversion.
    Emerick KM; Elias MS; Melin-Aldana H; Strautnieks S; Thompson RJ; Bull LN; Knisely As; Whitington PF; Green RM
    BMC Gastroenterol; 2008 Oct; 8():47. PubMed ID: 18937870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid treatment in children with Byler disease.
    Dinler G; Koçak N; Ozen H; Yüce A; Gürakan F
    Pediatr Int; 1999 Dec; 41(6):662-5. PubMed ID: 10618887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Sectional Analysis of Progressive Familial Intrahepatic Cholestasis in Puerto Rican Children.
    Soler DM; Del Valle AI; Fernandez-Lube D; Shneider BL
    P R Health Sci J; 2016 Dec; 35(4):220-223. PubMed ID: 27898169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A; Gervasi MT
    Clin Liver Dis; 2016 Feb; 20(1):177-89. PubMed ID: 26593298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical outcomes in Alagille syndrome and PFIC: A single institution's 20-year experience.
    Flores CD; Yu YR; Miloh TA; Goss J; Brandt ML
    J Pediatr Surg; 2018 May; 53(5):976-979. PubMed ID: 29729773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    J Gastroenterol Hepatol; 1999 Jun; 14(6):594-9. PubMed ID: 10385071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis.
    Vuoristo M; Färkkilä M; Gylling H; Karvonen AL; Leino R; Lehtola J; Makinen J; Mattila J; Tilvis R; Miettinen TA
    J Hepatol; 1997 Jul; 27(1):136-42. PubMed ID: 9252087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholestasis of pregnancy: a case report.
    Konjeti R; Selsky N
    Conn Med; 2012 Mar; 76(3):163-4. PubMed ID: 22666977
    [No Abstract]   [Full Text] [Related]  

  • 19. Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.
    Yang H; Porte RJ; Verkade HJ; De Langen ZJ; Hulscher JB
    J Pediatr Gastroenterol Nutr; 2009 Aug; 49(2):216-21. PubMed ID: 19561545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
    Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
    Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.